Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

buy

Biocryst Pharmaceuticals buy Wedbush

Biocryst Pharmaceuticals

Start price

€8.10

/ 50%

Target price

06.08.27

Performance (%)

Price

Summary

This prediction is currently active. The BUY prediction by Wedbush for Biocryst Pharmaceuticals is nearly unchanged. This prediction currently runs until 06.08.27. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction

Performance without dividends (%)

Name	1w
Biocryst Pharmaceuticals
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by Wedbush for this prediction

In the thread Biocryst Pharmaceuticals diskutieren

Prediction Buy

Perf. (%)

Target price 17.312

Change

Ends at

BioCryst Pharmaceuticals (BCRX) had its price target lowered by Wedbush from $21.00 to $20.00. They now have an "outperform" rating on the stock.

Ratings data for BCRX provided by MarketBeat

0

Stopped prediction by Wedbush for Biocryst Pharmaceuticals

Biocryst Pharmaceuticals

Start price

Target price

Perf. (%)

€7.43

07.05.27

50%

Biocryst Pharmaceuticals

Start price

Target price

Perf. (%)

€7.60

30.06.26

50%

Biocryst Pharmaceuticals

Start price

Target price

Perf. (%)

€7.80

25.02.26

50%